Bausch Health Companies (BHC) Competitors $7.68 +0.03 (+0.39%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BHC vs. QGEN, ITCI, ROIV, ASND, RVMD, LNTH, NUVL, LEGN, BPMC, and ELANShould you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), Lantheus (LNTH), Nuvalent (NUVL), Legend Biotech (LEGN), Blueprint Medicines (BPMC), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. Bausch Health Companies vs. Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Revolution Medicines Lantheus Nuvalent Legend Biotech Blueprint Medicines Elanco Animal Health Qiagen (NYSE:QGEN) and Bausch Health Companies (NYSE:BHC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings. Is QGEN or BHC more profitable? Qiagen has a net margin of 4.73% compared to Bausch Health Companies' net margin of -1.88%. Qiagen's return on equity of 13.43% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.73% 13.43% 8.10% Bausch Health Companies -1.88%-755.86%5.11% Do insiders and institutionals believe in QGEN or BHC? 70.0% of Qiagen shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 8.1% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer QGEN or BHC? In the previous week, Qiagen had 4 more articles in the media than Bausch Health Companies. MarketBeat recorded 10 mentions for Qiagen and 6 mentions for Bausch Health Companies. Qiagen's average media sentiment score of 0.81 beat Bausch Health Companies' score of 0.57 indicating that Qiagen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 4 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch Health Companies 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings & valuation, QGEN or BHC? Qiagen has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.97B5.26$341.30M$0.39116.26Bausch Health Companies$9.47B0.29-$592M-$0.48-16.00 Does the MarketBeat Community favor QGEN or BHC? Bausch Health Companies received 110 more outperform votes than Qiagen when rated by MarketBeat users. Likewise, 61.47% of users gave Bausch Health Companies an outperform vote while only 60.88% of users gave Qiagen an outperform vote. CompanyUnderperformOutperformQiagenOutperform Votes24960.88% Underperform Votes16039.12% Bausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% Do analysts prefer QGEN or BHC? Qiagen currently has a consensus price target of $51.15, suggesting a potential upside of 12.82%. Bausch Health Companies has a consensus price target of $7.75, suggesting a potential upside of 0.91%. Given Qiagen's stronger consensus rating and higher probable upside, equities research analysts clearly believe Qiagen is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, QGEN or BHC? Qiagen has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. SummaryQiagen beats Bausch Health Companies on 13 of the 18 factors compared between the two stocks. Ad WealthPressIs the Trump/Musk duo good for shares of TSLA?If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CompaniesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$2.78B$6.85B$5.14B$19.67BDividend YieldN/A3.06%4.81%3.51%P/E Ratio-16.0010.75135.1843.78Price / Sales0.29287.861,235.4217.61Price / Cash1.0556.6540.6521.73Price / Book-33.395.394.885.46Net Income-$592M$152.04M$118.97M$987.68M7 Day Performance1.25%-4.32%16.19%-2.32%1 Month Performance-8.35%2.80%16.02%0.63%1 Year Performance4.28%17.30%34.95%16.39% Bausch Health Companies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Companies2.7451 of 5 stars$7.68+0.4%$7.75+0.9%+5.5%$2.78B$9.47B-16.0020,270Short Interest ↑QGENQiagen4.2311 of 5 stars$45.45+0.1%$51.15+12.5%+3.6%$10.37B$1.97B117.035,967ITCIIntra-Cellular Therapies4.1678 of 5 stars$84.31+1.5%$97.23+15.3%+32.9%$8.94B$612.78M-95.91560ROIVRoivant Sciences2.667 of 5 stars$12.09+2.1%$17.93+48.3%+8.9%$8.80B$129.13M2.10860Positive NewsASNDAscendis Pharma A/S3.2197 of 5 stars$137.20+5.6%$191.77+39.8%+16.0%$8.32B$327.43M-16.52640Short Interest ↑RVMDRevolution Medicines4.6632 of 5 stars$44.77-0.5%$63.67+42.2%+69.6%$7.53B$11.58M-12.54443Positive NewsLNTHLantheus4.3734 of 5 stars$94.38+1.5%$130.00+37.7%+21.9%$6.56B$1.50B15.42834Positive NewsNUVLNuvalent2.3475 of 5 stars$86.53-0.4%$112.60+30.1%+9.7%$6.15BN/A-25.0340Positive NewsLEGNLegend Biotech1.6722 of 5 stars$33.61-4.3%$81.54+142.6%-43.4%$6.14B$520.18M-36.971,800BPMCBlueprint Medicines2.9172 of 5 stars$95.23+2.2%$122.11+28.2%+9.7%$6.05B$434.42M-45.28640Insider TradeShort Interest ↑ELANElanco Animal Health4.2802 of 5 stars$12.20+0.8%$16.75+37.3%-10.5%$6.03B$4.45B30.259,300 Related Companies and Tools Related Companies Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Revolution Medicines Alternatives Lantheus Alternatives Nuvalent Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BHC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
